Improving the Effect of Multiple Sclerosis Drugs by Chronobiology

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 8, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 2, 2023

Conditions
Multiple Sclerosis
Interventions
DEVICE

App randomizing dosing regimen

patients will receive their dimethyl fumarate treatment and the dose and time of administration will be determined using a designated app.

Trial Locations (1)

Unknown

Hadassah Medical Center, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER